ESLA
Estrella Immunopharma, Inc.
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Company with tickers: ESLA, ESLAW
CIK
1844417
CUSIP
297584104
Shares Outstanding
43,034,228
Website
https://www.estrellabio.com
Investor Relations
https://www.estrellabio.com/investors
13F Activity (30d)
1 filings
1 filers
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-05-27 | 226 | $1.15 | $260 |
| 2026-05-21 | 74 | $1.14 | $84 |
| 2026-04-30 | 783 | $1.47 | $1,151 |
| 2026-04-21 | 1,964 | $1.81 | $3,555 |
| 2026-04-20 | 5,209 | $1.88 | $9,793 |
| 2026-04-14 | 53 | $1.75 | $93 |
| 2026-04-13 | 10,175 | $1.84 | $18,722 |
| 2026-04-10 | 279 | $1.85 | $516 |
| 2026-04-09 | 14,152 | $1.92 | $27,172 |
| 2026-04-08 | 3,964 | $1.72 | $6,818 |
| 2026-04-07 | 7,291 | $1.36 | $9,916 |
| 2026-03-27 | 2 | $1.04 | $2 |
| 2026-03-26 | 900 | $0.98 | $882 |
| 2026-03-25 | 1,563 | $0.97 | $1,516 |
| 2026-03-24 | 2,601 | $1.02 | $2,653 |
Showing 1–15 of 15 settlements